The association of brachial flow-mediated dilation and high-sensitivity C-reactive protein levels with Duke treadmill score in patients with suspected microvascular angina

Experimental and Clinical Cardiology

Volumn 17, Issue 4, 2012, Pages 197-201

  Luo, Chufan ^a   Li, Yi ^a   Liu, Donghong ^a   Hu, Chengheng ^a   Du, Zhimin ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Exercise treadmill test; Flow mediated dilation; High sensitivity C reactive protein; Microvascular angina

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH SENSITIVITY C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DILATATION; ARTICLE; BLOOD SAMPLING; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRUG USE; EXERCISE ELECTROCARDIOGRAPHY; EXERCISE TEST; FAMILY HISTORY; FEMALE; FLOW MEDIATED DILATION; HEART CYCLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPEREMIA; HYPERTENSION; LIMIT OF DETECTION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; R WAVE; RESTING HEART RATE; SMOKING; ST SEGMENT DEPRESSION; SYNDROME X; SYSTOLIC BLOOD PRESSURE; THORAX PAIN; TREADMILL EXERCISE;

EID: 84872768543     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lekakis J P, Papamichael CM, Vemmos CN, et al. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 1998,31:541-6.
2. Arroyo-Espliguero R, Mollichelli N, Avanzas P, et al. Chronic inflammation and increased arterial stiffness in patients with cardia syndrome X. Eur Heart J 2003;24:2006-11.
3. Li AH, Lee BC, Chen KC, et al. Brachial artery flow-mediated vasodilation in patients with cardiac syndrome X. Angiology 2008;59:581-6.
4. Atmaca Y, Ozdol C, Turhan S, et al. The association of elevated white blood cell count and C-reactive protein with endothelial dysfunction in cardiac syndrome X. Acta Cardiol 2008;63:723-8.
5. Sakr SA, Abbas TM, Amer MZ, et al. Microvascular angina. The possible role of inflammation, uric acid, and endothelial dysfunction. Int Heart J 2009;50:407-19.
6. Tondi P, Santoliquido A, Di Giorgio A, et al. Endothelial dysfunction as assessed by flow-mediated dilation in patients with cardiac syndrome X: Role of inflammation. Eur Rev Med Pharmaco Sci 2011;15:1074-7.
7. Johnson GG, Decker WW, Lobl JK, et al. Risk stratification of patients in an emergency department chest pain unit: Prognostic value of exercise treadmill testing using the Duke score. Int J Emerg Med 2008;1:91-5.
8. Gulati M, Arnsdorf MF, Shaw LJ, et al. Prognostic value of the Duke treadmill score in asymptomatic women. Am J Cardiol 2005;96:369-75.
9. Lakkireddy DR, Bhakkad J, Korlakunta HL, et al. Prognostic value of the Duke Treadmill Score in diabetic patients. Am Heart J 2005;150:516-21.
10. Lai S, Kaykha A, Yamazaki T, et al. Treadmill scores in elderly men. J Am Coll Cardiol 2004;43:606-15.
11. Kwok JM, Miller TD, Hodge DO, et al. Prognostic value of the Duke treadmill score in the elderly. J Am Coll Cardiol 2002;39:1475-81.
12. Kwok JM, Miller TD, Christian TF, et al. Prognostic value of a treadmill exercise score in symptomatic patients with nonspecific ST-T abnormalities on resting ECG. JAMA 1999;282:1047-53.
13. Mark DB, Shaw L, Harrell FE Jr, et al. Prognostic value of a treadmill exercise score in outpatients with suspected coronary artery disease. N Engl J Med 1991;325:849-53.
14. Mark DB, Hlatky MA, Harrell FE Jr, et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 1987;106:793-800.
15. Youn HJ, Park CS, Moon K W, et al. Relation between Duke treadmill score and coronary flow reserve using transesophageal Doppler echocardiography in patients with microvascular angina. Int J Cardiol 2005;98:403-8.
16. Alexopoulos D, Olympios C, Christodoulou J, et al. Hyperventilation test in syndrome X. Angiology 1996;47:131-7.
17. Kayikcioglu M, Payzin S, Yavuzgil O, et al. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 2003;24:1999-2005.
18. Kemp HG Jr. Left ventricular function in patients with the anginal syndrome and normal coronary arteriograms. Am J Cardiol 1973;32:375-6.
19. Atienza F, Velasco JA, Brown S, et al. Assessment of quality of life in patients with chest pain and normal coronary arteriogram (syndrome X) using a specific questionnaire. Clin Cardiol 1999;22:283-90.
20. Chilian WM, Eastham CL, Layne SM, et al. Small vessel phenomena in the coronary microcirculation: Phasic intramyocardial perfusion and coronary microvascular dynamics. Prog Cardiovasc Dis 1988;31:17-38.
21. Mosseri M, Yarom R, Gotsman MS, et al. Histologic evidence for small-vessel coronary artery disease in patients with angina pectoris and patent large coronary arteries. Circulation 1986;74:964-72.
22. Cannon RO III, Schenke WH, Quyyumi A, et al. Comparison of exercise testing with studies of coronary flow reserve in patients with microvascular angina. Circulation 1991;83(5 Suppl):III77-81.
23. Di Monaco A, Bruno I, Sestito A, et al. Cardiac adrenergic nerve function and microvascular dysfunction in patients with cardiac syndrome X. Heart 2009;95:550-4.
24. Tousoulis D, Davies GJ, Asimakopoulos G, et al. Vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 serum level in patients with chest pain and normal coronary arteries (syndrome X). Clin Cardiol 2001;24:301-4.
25. Lanza GA, Luscher T F, Pasceri V, et al. Effects of atrial pacing on arterial and coronary sinus endothelin-1 levels in syndrome X. Am J Cardiol 1999;84:1187-91.
26. Kolasinska-Kloch W, Lesniak W, Kiec-Wilk B, et al. Biochemical parameters of endothelial dysfunction in cardiological syndrome X. Scand J Clin Lab Invest 2002;62:7-13.
27. Lanza GA, Buffon A, Sestito A, et al. Relation between stress-induced myocardial perfusion defects on cardiovascular magnetic resonance and coronary microvascular dysfunction in patients with cardiac syndrome X. J Am Coll Cardiol 2008;51:466-72.
28. Chauhan A, Mullins PA, Taylor G, et al. Both endothelium-dependent and endothelium-independent function is impaired in patients with angina pectoris and normal coronary angiograms. Eur Heart J 1997;18:60-8.
29. Masci PG, Laclaustra M, Lara JG, et al. Brachial artery flow-mediated dilation and myocardial perfusion in patients with cardiac syndrome X. Am J Cardiol 2005;95:1478-80.
30. Epstein SE, Cannon RO III, Bonow RO. Exercise testing in patients with microvascular angina. Circulation 1991;83(5 Suppl):III73-6.
31. Timurkaynak T, Balcioglu S, Arslan U, et al. Plasma homocysteine level in cardiac syndrome X and its relation with Duke treadmill score. Saudi Med J 2008;29:364-7.
32. Magarian GJ, Hickam DH. Noncardiac causes of angina-like chest pain. Prog Cardiovasc Dis 1986;29:65-80.
33. Magarian GJ, Mazur DJ. The hyperventilation challenge test. Another means of identifying coronary vasospasm in patients with angina-like chest pain. Chest 1991;99:199-204.
34. Vincent GM, Anderson JL, Marshall HW. Coronary spasm producing coronary thrombosis and myocardial infarction. N Engl J Med 1983;309:220-3.
35. Szlachcic J, Waters DD, Miller D, et al. Ventricular arrhythmias during ergonovine-induced episodes of variant angina. Am Heart J 1984;107:20-4.